 Elizabeth Sellars
Concepts (194)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intellectual Disability | 7 | 2022 | 127 | 1.090 |
Why?
| | Leukoencephalopathies | 1 | 2016 | 14 | 0.530 |
Why?
| | Acidosis | 1 | 2016 | 41 | 0.520 |
Why?
| | Thalamus | 1 | 2016 | 35 | 0.520 |
Why?
| | Brain Stem | 1 | 2016 | 57 | 0.520 |
Why?
| | Mitochondrial Diseases | 1 | 2016 | 45 | 0.510 |
Why?
| | Genetic Association Studies | 4 | 2019 | 124 | 0.510 |
Why?
| | Lactic Acid | 1 | 2016 | 78 | 0.510 |
Why?
| | Phenotype | 9 | 2022 | 799 | 0.490 |
Why?
| | Musculoskeletal Abnormalities | 2 | 2014 | 13 | 0.470 |
Why?
| | Corneal Diseases | 1 | 2014 | 15 | 0.440 |
Why?
| | Cornea | 1 | 2014 | 53 | 0.430 |
Why?
| | Joint Diseases | 1 | 2014 | 39 | 0.430 |
Why?
| | Focal Dermal Hypoplasia | 1 | 2013 | 2 | 0.430 |
Why?
| | Abnormalities, Multiple | 2 | 2018 | 167 | 0.420 |
Why?
| | Mutation | 8 | 2020 | 1351 | 0.410 |
Why?
| | Prenatal Diagnosis | 1 | 2013 | 103 | 0.400 |
Why?
| | Growth Disorders | 2 | 2017 | 64 | 0.380 |
Why?
| | Tetrasomy | 1 | 2011 | 2 | 0.360 |
Why?
| | Thumb | 1 | 2011 | 5 | 0.360 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2011 | 17 | 0.360 |
Why?
| | Alleles | 4 | 2019 | 277 | 0.350 |
Why?
| | Chromosome Disorders | 1 | 2011 | 32 | 0.350 |
Why?
| | Craniosynostoses | 1 | 2011 | 37 | 0.340 |
Why?
| | Mutation, Missense | 2 | 2021 | 108 | 0.330 |
Why?
| | Heart Ventricles | 1 | 2011 | 268 | 0.310 |
Why?
| | Neurodegenerative Diseases | 2 | 2020 | 81 | 0.300 |
Why?
| | Matrix Attachment Region Binding Proteins | 2 | 2018 | 37 | 0.250 |
Why?
| | Genotype | 5 | 2020 | 569 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 528 | 0.240 |
Why?
| | Infant | 8 | 2021 | 3684 | 0.230 |
Why?
| | Aortic Diseases | 2 | 2015 | 55 | 0.230 |
Why?
| | Nuclear Proteins | 2 | 2022 | 251 | 0.200 |
Why?
| | Transcription Factors | 2 | 2018 | 574 | 0.200 |
Why?
| | Nervous System Malformations | 1 | 2022 | 16 | 0.200 |
Why?
| | Male | 20 | 2022 | 26696 | 0.200 |
Why?
| | Iron-Sulfur Proteins | 2 | 2018 | 9 | 0.190 |
Why?
| | Oxidoreductases | 2 | 2018 | 59 | 0.180 |
Why?
| | Humans | 23 | 2022 | 52336 | 0.180 |
Why?
| | Osteochondrodysplasias | 1 | 2021 | 14 | 0.180 |
Why?
| | Female | 19 | 2022 | 28105 | 0.180 |
Why?
| | Brain Diseases | 1 | 2021 | 79 | 0.170 |
Why?
| | Neurofibromin 1 | 1 | 2019 | 11 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 205 | 0.160 |
Why?
| | Neurofibromatosis 1 | 1 | 2019 | 33 | 0.160 |
Why?
| | Child, Preschool | 9 | 2021 | 4030 | 0.160 |
Why?
| | Histones | 1 | 2020 | 316 | 0.150 |
Why?
| | Epilepsy | 1 | 2021 | 186 | 0.150 |
Why?
| | Sulfite Reductase (Ferredoxin) | 1 | 2017 | 2 | 0.140 |
Why?
| | Ferredoxins | 1 | 2017 | 3 | 0.140 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 16 | 0.140 |
Why?
| | Child | 10 | 2021 | 7157 | 0.140 |
Why?
| | Optic Atrophy | 1 | 2017 | 16 | 0.140 |
Why?
| | Muscular Dystrophies, Limb-Girdle | 1 | 2017 | 2 | 0.140 |
Why?
| | Spinocerebellar Degenerations | 1 | 2017 | 3 | 0.140 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2017 | 23 | 0.140 |
Why?
| | Glutamate-tRNA Ligase | 1 | 2016 | 4 | 0.130 |
Why?
| | Diagnosis, Differential | 2 | 2016 | 1044 | 0.130 |
Why?
| | Liver Diseases | 1 | 2016 | 83 | 0.130 |
Why?
| | Osteogenesis Imperfecta | 1 | 2016 | 37 | 0.120 |
Why?
| | Adolescent | 8 | 2021 | 6692 | 0.120 |
Why?
| | Collagen Type I | 1 | 2016 | 83 | 0.120 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2015 | 14 | 0.120 |
Why?
| | Zebrafish | 3 | 2021 | 60 | 0.120 |
Why?
| | Language Development Disorders | 1 | 2015 | 18 | 0.120 |
Why?
| | Young Adult | 7 | 2021 | 4319 | 0.120 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 27 | 0.120 |
Why?
| | Infant, Newborn | 4 | 2015 | 2826 | 0.120 |
Why?
| | Fractures, Bone | 1 | 2016 | 107 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2015 | 49 | 0.110 |
Why?
| | Homocysteine | 1 | 2015 | 126 | 0.110 |
Why?
| | Chromosome Duplication | 1 | 2014 | 7 | 0.110 |
Why?
| | Anterior Eye Segment | 1 | 2014 | 5 | 0.110 |
Why?
| | Galactosyltransferases | 1 | 2014 | 8 | 0.110 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2014 | 30 | 0.110 |
Why?
| | Urogenital Abnormalities | 1 | 2014 | 17 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 126 | 0.110 |
Why?
| | Aorta | 1 | 2015 | 169 | 0.110 |
Why?
| | Williams Syndrome | 1 | 2014 | 25 | 0.110 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2014 | 263 | 0.110 |
Why?
| | Cardiovascular Abnormalities | 1 | 2014 | 28 | 0.110 |
Why?
| | Child Abuse | 1 | 2016 | 140 | 0.110 |
Why?
| | Acyltransferases | 1 | 2013 | 25 | 0.110 |
Why?
| | Fatal Outcome | 1 | 2014 | 196 | 0.110 |
Why?
| | Animals | 9 | 2021 | 13523 | 0.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 150 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2018 | 506 | 0.100 |
Why?
| | Pregnancy | 3 | 2020 | 2675 | 0.100 |
Why?
| | Mice | 6 | 2021 | 5965 | 0.100 |
Why?
| | Gene Deletion | 1 | 2013 | 276 | 0.100 |
Why?
| | Cervical Vertebrae | 1 | 2011 | 62 | 0.090 |
Why?
| | Fetal Diseases | 1 | 2011 | 62 | 0.090 |
Why?
| | Microarray Analysis | 1 | 2011 | 69 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2013 | 340 | 0.090 |
Why?
| | Scoliosis | 1 | 2011 | 62 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2011 | 81 | 0.090 |
Why?
| | Bone and Bones | 1 | 2014 | 494 | 0.080 |
Why?
| | Adult | 6 | 2018 | 14139 | 0.080 |
Why?
| | Syndrome | 2 | 2021 | 247 | 0.080 |
Why?
| | HEK293 Cells | 2 | 2020 | 232 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2021 | 591 | 0.070 |
Why?
| | Coffee | 1 | 2007 | 11 | 0.070 |
Why?
| | Exome | 2 | 2017 | 55 | 0.060 |
Why?
| | Facies | 2 | 2018 | 36 | 0.060 |
Why?
| | Neurons | 2 | 2020 | 418 | 0.060 |
Why?
| | Brain | 3 | 2018 | 1323 | 0.060 |
Why?
| | Glucose | 1 | 2007 | 357 | 0.060 |
Why?
| | Genomic Imprinting | 1 | 2004 | 12 | 0.060 |
Why?
| | RNA, Untranslated | 1 | 2004 | 15 | 0.060 |
Why?
| | Chromosomes | 1 | 2004 | 30 | 0.060 |
Why?
| | Histone Demethylases | 1 | 2022 | 19 | 0.050 |
Why?
| | Face | 1 | 2022 | 56 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2016 | 6578 | 0.050 |
Why?
| | Echocardiography | 2 | 2015 | 412 | 0.050 |
Why?
| | Transcriptional Elongation Factors | 1 | 2021 | 17 | 0.050 |
Why?
| | Protein Stability | 1 | 2021 | 46 | 0.040 |
Why?
| | Proteins | 1 | 2004 | 354 | 0.040 |
Why?
| | Gene Frequency | 1 | 2021 | 99 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 24 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2021 | 95 | 0.040 |
Why?
| | Neuroglia | 1 | 2020 | 39 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 66 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2020 | 126 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2020 | 218 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2020 | 121 | 0.040 |
Why?
| | Models, Molecular | 1 | 2021 | 352 | 0.040 |
Why?
| | DNA Methylation | 1 | 2004 | 592 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 82 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 91 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2020 | 198 | 0.040 |
Why?
| | Gene Expression | 1 | 2020 | 623 | 0.040 |
Why?
| | Inheritance Patterns | 1 | 2018 | 22 | 0.040 |
Why?
| | Electron Transport | 1 | 2017 | 26 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2022 | 1006 | 0.040 |
Why?
| | Transcriptome | 1 | 2020 | 367 | 0.040 |
Why?
| | Mitochondrial Membranes | 1 | 2017 | 22 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2020 | 909 | 0.040 |
Why?
| | Mutagenesis | 1 | 2017 | 61 | 0.040 |
Why?
| | Dystroglycans | 1 | 2017 | 2 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 563 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 105 | 0.030 |
Why?
| | Iron | 1 | 2017 | 129 | 0.030 |
Why?
| | Glycosylation | 1 | 2017 | 106 | 0.030 |
Why?
| | Microcephaly | 1 | 2017 | 41 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 531 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 114 | 0.030 |
Why?
| | Pathology, Molecular | 1 | 2016 | 28 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 186 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 26 | 0.030 |
Why?
| | Frameshift Mutation | 1 | 2015 | 18 | 0.030 |
Why?
| | Homocystinuria | 1 | 2015 | 8 | 0.030 |
Why?
| | Muscle Spasticity | 1 | 2015 | 13 | 0.030 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2015 | 25 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2015 | 28 | 0.030 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2015 | 58 | 0.030 |
Why?
| | Cell Line | 1 | 2017 | 1045 | 0.030 |
Why?
| | Heart Valve Diseases | 1 | 2015 | 53 | 0.030 |
Why?
| | Genetic Testing | 1 | 2015 | 130 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 230 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 17 | 0.030 |
Why?
| | Lipoma | 1 | 2014 | 18 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2014 | 39 | 0.030 |
Why?
| | Nevus | 1 | 2014 | 16 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 1676 | 0.030 |
Why?
| | Methionine | 1 | 2015 | 136 | 0.030 |
Why?
| | Inflammation | 1 | 2018 | 642 | 0.030 |
Why?
| | Cleft Palate | 1 | 2015 | 79 | 0.030 |
Why?
| | Organ Specificity | 1 | 2014 | 117 | 0.030 |
Why?
| | Mitochondria | 1 | 2017 | 428 | 0.030 |
Why?
| | Age of Onset | 1 | 2014 | 109 | 0.030 |
Why?
| | Hyperplasia | 1 | 2014 | 98 | 0.030 |
Why?
| | Aortic Valve | 1 | 2015 | 123 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2014 | 155 | 0.030 |
Why?
| | Psychotic Disorders | 1 | 2015 | 139 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 179 | 0.030 |
Why?
| | Comorbidity | 1 | 2015 | 624 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2014 | 204 | 0.020 |
Why?
| | Vascular Malformations | 1 | 2014 | 103 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 1903 | 0.020 |
Why?
| | Prevalence | 1 | 2015 | 1007 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 1021 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 1484 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 809 | 0.020 |
Why?
| | Signal Transduction | 1 | 2017 | 1716 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 2015 | 618 | 0.020 |
Why?
| | Caffeine | 1 | 2007 | 61 | 0.020 |
Why?
| | Risk Factors | 1 | 2015 | 3872 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2015 | 5407 | 0.010 |
Why?
| | Gene Silencing | 1 | 2004 | 119 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 1552 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2004 | 146 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2004 | 265 | 0.010 |
Why?
| | Rats | 1 | 2007 | 3202 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 13014 | 0.010 |
Why?
|
|
Sellars's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|